ACT METHYLPHENIDATE ER
TEVA CANADA LIMITED
Quick answers
Is there a shortage of ACT METHYLPHENIDATE ER in Canada?
No. There is no current shortage of ACT METHYLPHENIDATE ER 27MG reported to Health Canada. Stock can still vary from one pharmacy to another.
ADHD Medication Shortage in Canada: What to Know
Why ADHD medications go into shortage in Canada more often than most drug classes, which ones are most affected, and what to do if yours is short-supplied.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
Other Products
PMS-METHYLPHENIDATE
PHARMASCIENCE INC
PHL-METHYLPHENIDATE
PHARMEL INC
METHYLPHENIDATE TAB 10MG
TECHNILAB PHARMA INC.
RATIO-METHYLPHENIDATE
TEVA CANADA LIMITED
METHYLPHENIDATE TAB 20MG
TECHNILAB PHARMA INC.
DIN
02441942
Strength
27MG
Dosage Form
Tablet (Extended-Release)
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02143933
DIN 00834319
3.5MG · DIN 02438399
0.5MG · DIN 02301407
100MG · DIN 02420155
200MG · DIN 02420163
500MG · DIN 02247340
750MG · DIN 02247341
250MG · DIN 02247339
75MG · DIN 02303027
180MG · DIN 02370638
240MG · DIN 02370646